Literature DB >> 11433243

Evolving paradigms in biotech IPO valuations.

S Papadopoulos1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11433243     DOI： 10.1038/89401

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Do executives' backgrounds matter to IPO investors? Evidence from the life science industry.

Authors:  Jay Chok; Jifeng Qian
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.